Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial-Reference-Cited by-同舟云学术

Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial

Published:2021-01 Issue:1 Volume:6 Page:17-29
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Garin Etienne,Tselikas Lambros,Guiu Boris,Chalaye Julia,Edeline Julien,de Baere Thierry,Assenat Eric,Tacher Vania,Robert Corentin,Terroir-Cassou-Mounat Marie,Mariano-Goulart Denis,Amaddeo Giuliana,Palard Xavier,Hollebecque Antoine,Kafrouni Marilyne,Regnault Hélène,Boudjema Karim,Grimaldi Serena,Fourcade Marjolaine,Kobeiter Hicham,Vibert Eric,Le Sourd Samuel,Piron Lauranne,Sommacale Danièle,Laffont Sophie,Campillo-Gimenez Boris,Rolland Yan,Garin Etienne,Edeline Julien,Robert Corentin Robert,Le Sourd Samuel,Palard Xavier,Laffont Sophie,Campillo-Gimenez Boris,Rolland Yan,Pracht Marc,Ardisson Valérie,Lenoir Laurence,Boudjema Karim,Tselikas Lambros,De Baere Thierry,Terroir-Cassou-Mounat Marie,Hollebecque Antoine,Grimaldi Serena,Deschamps Frederic,Ducreux Michel,Gelli Maximiliano,Vibert Eric,Guiu Boris,Piron Lauranne,Kafrouni Marilyne,Fourcade Marjolaine,Assenat Eric,Mariano-Goulart Denis,Cassinotto Christophe,Allimant Carole,Chalaye Julia,Regnault Hélène,Amaddeo Giuliana,Sommacale Danièle,Kobeiter Hicham,Tacher Vania,Bonnot-Lours Sophie,Marie Margarita,Itti Emmanuel,Lerman Lionel,Abulizi Mukedaisi,Luciani Alain,Costentin Charlotte E.,Milliner Milan

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference32 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015

2. Hepatocellular carcinoma: a review;Balogh;J Hepatocell Carcinoma,2016

3. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med,2008

4. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma;Finn;N Engl J Med,2020

5. Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study;Lau;Br J Cancer,1994

Cited by 390 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic factors influencing outcomes in hepatocellular carcinoma patients undergoing selective internal radiation therapy;Annals of Hepatology;2025-01

2. Ipilimumab and nivolumab plus radioembolization as salvage therapy for atezolizumab and bevacizumab refractory hepatocellular carcinoma resulting in complete pathologic response;Radiology Case Reports;2024-11

3. Precision individual dosimetry in Yttrium-90 transarterial radioembolization in the presence of Au nanoparticles;Radiation Physics and Chemistry;2024-09

4. Multidisciplinary Delphi Consensus on Safety of Combining Transarterial Radioembolization with Yttrium-90 Microspheres with Systemic Anticancer Agents for the Treatment of Liver Malignancy;Journal of Vascular and Interventional Radiology;2024-09

5. Advancing Radioembolization Through Personalized Dosimetry;Advances in Clinical Radiology;2024-09